Investigations on Clinical Validation of mutated ANKRD36 as a Novel Molecular Biomarker for Monitoring Early Progression and Timely Therapeutic Interventions in Blast Crisis CML

Nawaf Alanazi, Abdulaziz Siyal, Muhammad Absar, Masood Shammas, Amer Mahmood, Sulman Basit, Sarah AlMukhaylid, Zafar Iqbal
doi: https://doi.org/10.1101/2023.12.28.23300606

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted December 29, 2023.
Download PDF
Data/Code
Email
Investigations on Clinical Validation of mutated ANKRD36 as a Novel Molecular Biomarker for Monitoring Early Progression and Timely Therapeutic Interventions in Blast Crisis CML
Nawaf Alanazi, Abdulaziz Siyal, Muhammad Absar, Masood Shammas, Amer Mahmood, Sulman Basit, Sarah AlMukhaylid, Zafar Iqbal
medRxiv 2023.12.28.23300606; doi: https://doi.org/10.1101/2023.12.28.23300606
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area